ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/30/2025
Back to search
Official data from USPTO
ELIXIR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
05/01/2025
Classification
Registered
Trademark type
Word
Nice classes
35
Filing date
03/16/2020
Registration date
11/08/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2022
Last transaction
05/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/19/2020
First use in commerce
09/01/2020
Drawing code
4
Owner type
16
Owner location
TWINSBURG, OH
Examiner
STURMAN, JOSHUA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ELIXIR HOLDINGS, LLC
ELIXIR HOLDINGS, LLC
Representatives
Amanda H. Wilcox Taft Stettinius & Hollister LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business administration servicesdeveloping and maintaining formularycontracting with pharmacies and negotiating discounts and rebates with drug manufacturers; Pharmaceutical cost management services for pharmaceuticals covered by commercial insurance and not covered by insurance provided to pharmacies; Pharmaceutical cost management services for pharmaceuticals covered by commercial insurance and not covered by insurance provided to consumers; Administering discount group purchasing programsnegotiating contracts with pharmacies to enable participant consumersboth those covered and not covered by commercial insuranceto obtain discounts on the purchase of pharmaceuticals; health care cost management services for others; marketing of pharmaceutical products for others; administration of a discount program for pharmaceuticals not covered by insurancethrough use of a discount cardfor consumers; administration of a non-insurance discount program for pharmaceuticals covered by separate commercial insurance enabling participant consumers to obtain additional discountsthrough use of a discount card
Publications
History of USPTO decisions and trademark events.
56 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/21/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/27/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/27/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/27/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/05/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/04/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/28/2022
IUAF
USE AMENDMENT FILED
06/24/2022
EISU
TEAS STATEMENT OF USE RECEIVED
06/24/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/23/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/14/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/19/2022
PUBO
PUBLISHED FOR OPPOSITION
04/19/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2022
ALIE
ASSIGNED TO LIE
02/17/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/14/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/09/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/02/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/29/2021
GNSL
LETTER OF SUSPENSION E-MAILED
04/29/2021
CNSL
SUSPENSION LETTER WRITTEN
04/29/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/10/2021
GNFR
FINAL REFUSAL E-MAILED
02/10/2021
CNFR
FINAL REFUSAL WRITTEN
02/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/27/2021
ATRV
ATTORNEY REVIEW COMPLETED
10/30/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
10/22/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/15/2020
DRRR
DIVISIONAL REQUEST RECEIVED
08/27/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/27/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/30/2020
GNRT
NON-FINAL ACTION E-MAILED
07/30/2020
CNRT
NON-FINAL ACTION WRITTEN
07/30/2020
DOCK
ASSIGNED TO EXAMINER
06/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/23/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/23/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/20/2020
NWAP
NEW APPLICATION ENTERED
03/19/2020
Continuous trademark protection
Get notified about every new filing that threatens ELIXIR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.